Drug & intervention
ascorbic acid 125 MG / iron carbonyl 65 MG [Vitron-C Reformulated Jul 2016]
RxCUI 1799174
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
Vitron-C Reformulated Jul 2016BN · CureCurrent ID 63614
ascorbic acid / iron carbonyl Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]SBDF · CureCurrent ID 65372
ascorbic acid 125 MG / iron carbonyl 65 MG Delayed Release Oral Tablet [Vitron-C Reformulated Jul 2016]SBD · CureCurrent ID 63616
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.